(Q64272299)

English

The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysis

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

0 references

1 reference

3 October 2022

The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

cutaneous leishmaniasis

4 references

22 June 2019

17 June 2019

7 November 2019

12 November 2019

visceral leishmaniasis

4 references

22 June 2019

17 June 2019

7 November 2019

12 November 2019

1 reference

7 November 2019

1 reference

12 November 2019

infectious disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

author name string

Margriet L den Boer

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

Dirk R Essink

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

Koert Ritmeijer

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

language of work or name

0 references

publication date

11 February 2019

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

1 February 2019

1 reference

3 October 2022

PLoS Neglected Tropical Diseases

6 references

22 June 2019

17 June 2019

7 November 2019

12 November 2019

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

3 October 2022

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

e0007173

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

copyright license

Creative Commons Attribution 4.0 International

5 references

Europe PubMed Central

22 June 2019

Europe PubMed Central

17 June 2019

Europe PubMed Central

7 November 2019

Europe PubMed Central

12 November 2019

Europe PubMed Central

3 October 2022

on focus list of Wikimedia project

0 references

A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral miltefosine for the treatment of Indian visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developments in the treatment of visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inadequacy of 12-Week Miltefosine Treatment for Indian Post-Kala-Azar Dermal Leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corneal complications following Post Kala-azar Dermal Leishmaniasis treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/30742620

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PNTD.0007173

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30742620 AND SRC:MED&resulttype=core&format=json

22 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64272299&oldid=1742566552"